| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.1 |